About Jay Offen
Form D filings for BioMEMS Diagnostics in 2023 list Jay Offen as executive officer and director.
Jay Offen first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jay Offen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jay Offen works with at each company, as listed on that company's latest Form D.
BioMEMS Diagnostics, Inc. · Form D, Jan 17, 2023
MP
Michael Pugia
Executive officer
ZB
Zaine Baird
Executive officer
CF
Casey Fowler
President & CEO, director
AD
Andrew Dahl
Executive officer, director and promoter
JB
John Bohan
Executive officer